| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.81▲ | 7.81▲ | 7.79▲ | 7.78▲ | 7.86▼ |
| MA10 | 7.81▲ | 7.79▲ | 7.80▲ | 7.95▼ | 7.56▲ |
| MA20 | 7.81▲ | 7.80▲ | 7.72▲ | 7.91▼ | 7.68▲ |
| MA50 | 7.81▲ | 7.74▲ | 7.88▼ | 7.68▲ | 8.11▼ |
| MA100 | 7.73▲ | 7.89▼ | 7.93▼ | 7.70▲ | 10.55▼ |
| MA200 | 7.83▼ | 7.90▼ | 7.67▲ | 8.00▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.001▲ | 0.018▲ | -0.038▼ | 0.110▲ |
| RSI | 52.149▲ | 54.148▲ | 52.647▲ | 50.386▲ | 49.837▼ |
| STOCH | 52.372 | 56.167 | 40.888 | 38.860 | 59.521 |
| WILL %R | -35.294 | -48.718 | -33.333 | -60.215 | -39.306 |
| CCI | -16.260 | 29.442 | 55.197 | -71.938 | 33.648 |
| CDL | $GYRE Harami Candlestick Pattern Detected | Set Alert |
|
Monday, January 05, 2026 04:00 AM
SAN DIEGO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Gyre Therapeutics, Inc. (Gyre or the Company) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing ...
|
|
Sunday, January 04, 2026 11:01 PM
Gyre Pharmaceuticals completed a Pre-NDA meeting with China’s CDE, which agreed that the existing Phase 3 clinical data support a conditional approval filing for Hydronidone and priority review ...
|
|
Friday, November 07, 2025 05:53 AM
(RTTNews) - GYRE THERAPEUTICS, INC. (GYRE) reported a profit for its third quarter that Increased, from the same period last year The company's earnings came in at $3.61 million, or $0.03 per share.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 09/02/26 | 7.865 | 7.865 | 7.72 | 7.82 | 19,082 |
| 06/02/26 | 7.64 | 7.90 | 7.58 | 7.88 | 47,500 |
| 05/02/26 | 7.70 | 7.85 | 7.45 | 7.51 | 46,500 |
| 04/02/26 | 7.84 | 7.92 | 7.60 | 7.77 | 46,200 |
| 03/02/26 | 8.21 | 8.21 | 7.74 | 7.92 | 42,500 |
| 02/02/26 | 8.08 | 8.28 | 7.98 | 8.21 | 131,094 |
| 30/01/26 | 8.08 | 8.25 | 7.97 | 8.09 | 91,800 |
| 29/01/26 | 8.07 | 8.25 | 7.84 | 8.21 | 100,200 |
| 28/01/26 | 8.04 | 8.17 | 7.985 | 8.03 | 78,667 |
| 27/01/26 | 7.89 | 8.09 | 7.78 | 8.09 | 53,700 |
|
|
||||
|
|
||||
|
|